Charlotte's Web Holdings, Inc.: Charlotte's Web Announces DeFloria to enter Phase 2 FDA Clinical Trial for Autism Spectrum Disorder Treatment
"Progressing to Phase 2 of an IND study with the FDA marks an important milestone in the development of our proprietary hemp genetics as regulated medicine," said Bill Morachnick, Chief Executive ...
Charlotte's Web Announces Defloria To Enter Phase 2 FDA Clinical Trial For Autism Spectrum Disorder Treatment
Charlotte's Web Holdings, Inc. (" Charlotte's Web " or the " Company "), a market leader in hemp extract wellness products, is pleased to announce that the U.S. Food and Drug Administration (FDA) has ...